These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 7758676)

  • 41. Discovery of novel peptidic dopamine transporter ligands by screening a positional scanning combinatorial hexapeptide library.
    Rothman RB; Baumann MH; Dersch CM; Appel J; Houghten RA
    Synapse; 1999 Sep; 33(3):239-46. PubMed ID: 10420171
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tails of serotonin and norepinephrine transporters: deletions and chimeras retain function.
    Blakely RD; Moore KR; Qian Y
    Soc Gen Physiol Ser; 1993; 48():283-300. PubMed ID: 8503051
    [No Abstract]   [Full Text] [Related]  

  • 43. 5-ht5B receptor mRNA in the raphe nuclei: coexpression with serotonin transporter.
    Serrats J; Raurich A; Vilaró MT; Mengod G; Cortés R
    Synapse; 2004 Feb; 51(2):102-11. PubMed ID: 14618677
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Monoclonal antibodies to a brain dopamine binding protein: production, specificity, and immunohistochemistry.
    Hsu LL; Moroi K; Lakchaura BD; Chan T; Lin CT; Wu JY
    J Neurosci Res; 1987; 17(4):417-23. PubMed ID: 3305971
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Serotonin transporter localization in the hamster suprachiasmatic nucleus.
    Legutko R; Gannon RL
    Brain Res; 2001 Mar; 893(1-2):77-83. PubMed ID: 11222995
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Acute and chronic effects of nicotine on serotonin uptake in prefrontal cortex and hippocampus of rats.
    Awtry TL; Werling LL
    Synapse; 2003 Dec; 50(3):206-11. PubMed ID: 14515338
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Interactions of antidepressants with the serotonin transporter: a contemporary molecular analysis.
    Roman DL; Walline CC; Rodriguez GJ; Barker EL
    Eur J Pharmacol; 2003 Oct; 479(1-3):53-63. PubMed ID: 14612137
    [TBL] [Abstract][Full Text] [Related]  

  • 48. High-dose fenfluramine administration decreases serotonin transporter binding, but not serotonin transporter protein levels, in rat forebrain.
    Rothman RB; Jayanthi S; Wang X; Dersch CM; Cadet JL; Prisinzano T; Rice KC; Baumann MH
    Synapse; 2003 Dec; 50(3):233-9. PubMed ID: 14515341
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Platelet 5-hydroxytryptamine (5-HT) transporter and 5-HT2A receptor binding after chronic hypercorticosteronemia, (+/-)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane administration or neurotoxin-induced depletion of central nervous system 5-HT in the rat.
    Owens MJ; Ballenger CA; Knight DL; Nemeroff CB
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1040-9. PubMed ID: 8819484
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interaction of lectins with human platelet serotonin transporter.
    Helmeste DM; Chudzik J; Tang SW
    Eur J Pharmacol; 1994 Feb; 266(3):327-31. PubMed ID: 8174615
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Generation of transporter-specific antibodies.
    Miller GW; Gilmor ML; Levey AI
    Methods Enzymol; 1998; 296():407-22. PubMed ID: 9779463
    [No Abstract]   [Full Text] [Related]  

  • 52. Examination of glutamate transporter heterogeneity using synaptosomal preparations.
    Robinson MB
    Methods Enzymol; 1998; 296():189-202. PubMed ID: 9779449
    [No Abstract]   [Full Text] [Related]  

  • 53. Analysis of serotonin transporter in human platelets by immunoblotting using site-specific antibodies.
    Dmitriev AD; Pavlova EV; Factor MI; Segal OL; Massino YS; Dobrohotov IV; Smirnova MB; Hwun DE; Yakovleva DA; Kolyaskina GI; Brusov OS
    Biochemistry (Mosc); 2004 Jun; 69(6):629-41. PubMed ID: 15236602
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Relationship between [125I]RTI-55-labeled cocaine binding sites and the serotonin transporter in rat placenta.
    Shearman LP; McReynolds AM; Zhou FC; Meyer JS
    Am J Physiol; 1998 Dec; 275(6):C1621-9. PubMed ID: 9843724
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In vitro activity of LY393558, an inhibitor of the 5-hydroxytryptamine transporter with 5-HT(1B/1D/2) receptor antagonist properties.
    Pullar IA; Boot JR; Carney SL; Cohen ML; Colvin EM; Conway RG; Hardy CH; Lucaites VL; Nelson DL; Schenck KW; Tomlinson R; Wedley S
    Eur J Pharmacol; 2001 Nov; 432(1):9-17. PubMed ID: 11734182
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Localized decrease in serotonin transporter-immunoreactive axons in the prefrontal cortex of depressed subjects committing suicide.
    Austin MC; Whitehead RE; Edgar CL; Janosky JE; Lewis DA
    Neuroscience; 2002; 114(3):807-15. PubMed ID: 12220580
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunocytochemical localization of serotonin and serotonin transporter (SET) in taste buds of rat.
    Ren Y; Shimada K; Shirai Y; Fujimiya M; Saito N
    Brain Res Mol Brain Res; 1999 Dec; 74(1-2):221-4. PubMed ID: 10640694
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification of the protein responsible for hepatic system N amino acid transport activity.
    Tamarappoo BK; Handlogten ME; Laine RO; Serrano MA; Dugan J; Kilberg MS
    J Biol Chem; 1992 Feb; 267(4):2370-4. PubMed ID: 1733938
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Production of C- and N-terminus-specific anti-(GAP-43) antibodies.
    Wiese UH; Emson PC; Sheppard RC
    Biochem Soc Trans; 1989 Dec; 17(6):1058-9. PubMed ID: 2628079
    [No Abstract]   [Full Text] [Related]  

  • 60. The state of the serotonin transporter protein in the platelets of patients with somatoform [correction of somatiform] disorders.
    Belous AR; Ramamoorthy S; Blakely RD; Factor MI; Dupin AM; Katasonov AB; Lozier RH; Beniashvili AG; Morozova MA; Brusov OS
    Neurosci Behav Physiol; 2001; 31(2):185-9. PubMed ID: 11392354
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.